Related references
Note: Only part of the references are listed.Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
David W. Denning et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Threshold of galactomannan antigenemia positivity for early diagnosis of invasive aspergillosis in neutropenic children
Veronique Dinand et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2016)
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
Johan A. Maertens et al.
LANCET (2016)
Combination Antifungal Therapy for Invasive Aspergillosis A Randomized Trial
Kieren A. Marr et al.
ANNALS OF INTERNAL MEDICINE (2015)
Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological Malignancies
Aaron Cumpston et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection
Thomas H. Price et al.
BLOOD (2015)
Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing
P. Lewis White et al.
CLINICAL INFECTIOUS DISEASES (2015)
High Resolution Computed Tomography Angiography Improves the Radiographic Diagnosis of Invasive Mold Disease in Patients With Hematological Malignancies
Marta Stanzani et al.
CLINICAL INFECTIOUS DISEASES (2015)
PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ Transplant
Agnieszka Wojtowicz et al.
CLINICAL INFECTIOUS DISEASES (2015)
Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent
Marisa H. Miceli et al.
CLINICAL INFECTIOUS DISEASES (2015)
Antibody testing in aspergillosis-quo vadis?
Iain D. Page et al.
MEDICAL MYCOLOGY (2015)
Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1 -> 3)-beta-D-glucan in experimental invasive pulmonary aspergillosis
Ruta Petraitiene et al.
MEDICAL MYCOLOGY (2015)
Serum posaconazole levels among haematological cancer patients taking extended release tablets is affected by body weight and diarrhoea: single centre retrospective analysis
Marisa H. Miceli et al.
MYCOSES (2015)
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation: A Prospective Phase II Trial
Maddalena Giannella et al.
TRANSPLANTATION (2015)
The Effectiveness of Culture-Directed Preemptive Anti-Aspergillus Treatment in Lung Transplant Recipients at One Year After Transplant
Seyed M. Hosseini-Moghaddam et al.
TRANSPLANTATION (2015)
Serum Galactomannan Versus a Combination of Galactomannan and Polymerase Chain Reaction-Based Aspergillus DNA Detection for Early Therapy of Invasive Aspergillosis in High-Risk Hematological Patients: A Randomized Controlled Trial
Jose Maria Aguado et al.
CLINICAL INFECTIOUS DISEASES (2015)
Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: A systematic review and meta-analysis
Siow Chin Heng et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2015)
Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA)
Livingstone Chishimba et al.
JOURNAL OF ASTHMA (2015)
IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation
Agnieszka Wojtowicz et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation
Gary D. Peksa et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2015)
Pulmonary Arterial Mycotic Pseudoaneurysms in a Patient with Invasive Pulmonary Aspergillosis Successful Occlusion by Coils
Morgane Didier et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Epidemiology of Invasive Mold Infections in Lung Transplant Recipients
C. T. Doligalski et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea
Jin Seok Kim et al.
ANNALS OF HEMATOLOGY (2014)
Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study
John W. Baddley et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Video-Assisted Thoracic Surgery for Pulmonary Aspergilloma: A Safe and Effective Procedure
Qian-Kun Chen et al.
ANNALS OF THORACIC SURGERY (2014)
Surgical Therapy of Pulmonary Aspergillomas: A 30-Year North American Experience
Ashok Muniappan et al.
ANNALS OF THORACIC SURGERY (2014)
Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with Neutropenia
Rafael F. Duarte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Switching from Posaconazole Suspension to Tablets Increases Serum Drug Levels in Leukemia Patients without Clinically Relevant Hepatotoxicity
Dong Sik Jung et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Antifungal Agents for Secondary Prophylaxis Based on Response to Initial Antifungal Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Prior Pulmonary Aspergillosis
Qifa Liu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Orbital aspergillosis in immunocompetent patients
Kruti H. Mody et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2014)
Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review
A. S. Moreira et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
The Reversed Halo Sign: Pathognomonic Pattern of Pulmonary Mucormycosis in Leukemic Patients With Neutropenia?
C. Legouge et al.
CLINICAL INFECTIOUS DISEASES (2014)
Antifungal Combination Therapy for Invasive Aspergillosis
Almudena Martin-Pena et al.
CLINICAL INFECTIOUS DISEASES (2014)
Plasma Fluoride Level as a Predictor of Voriconazole-Induced Periostitis in Patients With Skeletal Pain
Woo J. Moon et al.
CLINICAL INFECTIOUS DISEASES (2014)
Serum Galactomannan-Based Early Detection of Invasive Aspergillosis in Hematology Patients Receiving Effective Antimold Prophylaxis
Rafael F. Duarte et al.
CLINICAL INFECTIOUS DISEASES (2014)
Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study
N. Lerolle et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
A prominent role for the IL1 pathway and IL15 in susceptibility to chronic cavitary pulmonary aspergillosis
N. L. D. Smith et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Reduced expression of TLR3, TLR10 and TREM1 by human macrophages in Chronic cavitary pulmonary aspergillosis, and novel associations of VEGFA, DENND1B and PLAT
N. L. D. Smith et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Update on antifungal resistance in Aspergillus and Candida
M. C. Arendrup
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Antifungal drug resistance mechanisms in pathogenic fungi: from bench to bedside
M. Cuenca-Estrella
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Predictors of mortality in non-neutropenic patients with invasive pulmonary aspergillosis: does galactomannan have a role?
Alessandro Russo et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2014)
A retrospective review comparing the treatment outcomes of emergency lung resection for massive haemoptysis with and without preoperative bronchial artery embolization
Gerard R. Alexander
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2014)
Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis
Richard B. Moss
EUROPEAN RESPIRATORY JOURNAL (2014)
Fungal infections of the skin and nail: new treatment options
Matthew L. Eldridge et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2014)
Clinical implications of interferon-γ genetic and epigenetic variants
Nicola L. D. Smith et al.
IMMUNOLOGY (2014)
Diagnosis and Management of Fungal Urinary Tract Infection
Carol A. Kauffman
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2014)
Voriconazole pharmacokinetics and exposure-response relationships: Assessing the links between exposure, efficacy and toxicity
Michael J. Dolton et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
H. Ruth Ashbee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model
Maria Siopi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing
Michael J. Dolton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Reduction in False-Positive Aspergillus Serum Galactomannan Enzyme Immunoassay Results Associated with Use of Piperacillin-Tazobactam in the United States
Paschalis Vergidis et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Use and Limits of (1-3)-β-D-Glucan Assay (Fungitell), Compared to Galactomannan Determination (Platelia Aspergillus), for Diagnosis of Invasive Aspergillosis
Annie Sulahian et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
PCR in Diagnosis of Invasive Aspergillosis: a Meta-Analysis of Diagnostic Performance
Marios Arvanitis et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Serum galactomannan antigen test for the diagnosis of chronic pulmonary aspergillosis
Beomsu Shin et al.
JOURNAL OF INFECTION (2014)
Aspergillus osteomyelitis: Epidemiology, clinical manifestations, management, and outcome
Maria N. Gamaletsou et al.
JOURNAL OF INFECTION (2014)
Recurrence of chronic pulmonary aspergillosis after discontinuation of maintenance treatment by antifungal triazoles
Kazuya Koyama et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2014)
Voriconazole Metabolism, Toxicity, and the Effect of Cytochrome P450 2C19 Genotype
Dimitrios Zonios et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Role of inhaled amphotericin in allergic bronchopulmonary aspergillosis
I. S. Sehgal et al.
JOURNAL OF POSTGRADUATE MEDICINE (2014)
Antifungal Susceptibility Profile of Cryptic Species of Aspergillus
Ana Alastruey-Izquierdo et al.
MYCOPATHOLOGIA (2014)
Empirical Amphotericin B therapy on Day 4 or Day 8 of Febrile Neutropenia
Pankaj Malhotra et al.
MYCOSES (2014)
Volume dependency for culture of fungi from respiratory secretions and increased sensitivity of Aspergillus quantitative PCR
Marcin G. Fraczek et al.
MYCOSES (2014)
Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real-life combo study
A. Candoni et al.
MYCOSES (2014)
Cut-off values of serum IgE (total and A. fumigatus -specific) and eosinophil count in differentiating allergic bronchopulmonary aspergillosis from asthma
Ritesh Agarwal et al.
MYCOSES (2014)
Amphotericin forms an extramembranous and fungicidal sterol sponge
Thomas M. Anderson et al.
NATURE CHEMICAL BIOLOGY (2014)
Adverse Health Effects of Marijuana Use
Valerie Wolff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation
Cristina Cunha et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mold Infections of the Central Nervous System
Matthew McCarthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Omalizumab Therapy for Allergic Bronchopulmonary Aspergillosis in Children with Cystic Fibrosis: A Synthesis of Published Evidence
Kalliopi Tanou et al.
PEDIATRIC PULMONOLOGY (2014)
Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis
Louis Yi Ann Chai et al.
PLOS ONE (2014)
Multi-Country Estimate of Different Manifestations of Aspergillosis in Cystic Fibrosis
Joanne Armstead et al.
PLOS ONE (2014)
Reversed Halo Sign: A Systematic Review
Venkata N. Maturu et al.
RESPIRATORY CARE (2014)
Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis
Gregory J. Keir et al.
THORAX (2014)
Independent contribution of bronchoalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis
C. E. Fisher et al.
TRANSPLANT INFECTIOUS DISEASE (2014)
Microwave ablation of a large renal aspergilloma
S. Waller et al.
TRANSPLANT INFECTIOUS DISEASE (2014)
Pretransplant Aspergillus Colonization of Cystic Fibrosis Patients and the Incidence of PostYLung Transplant Invasive Aspergillosis
Me-Linh Luong et al.
TRANSPLANTATION (2014)
MRI of CNS Fungal Infections: Review of Aspergillosis to Histoplasmosis and Everything in Between
J. Starkey et al.
CLINICAL NEURORADIOLOGY (2014)
Medical management of allergic fungal rhinosinusitis following endoscopic sinus surgery: an evidence-based review and recommendations
Eng Cern Gan et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2014)
Omalizumab for the Treatment of Inadequately Controlled Allergic Rhinitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Sophia Tsabouri et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2014)
Fungal allergy in asthma-state of the art and research needs
David W. Denning et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2014)
Survey of Academic Pulmonologists, Oncologists, and Infectious Disease Physicians on the Role of Bronchoscopy in Managing Hematopoietic Stem Cell Transplantation Patients With Pulmonary Infiltrates
Ali S. Wahla et al.
JOURNAL OF BRONCHOLOGY & INTERVENTIONAL PULMONOLOGY (2014)
Diagnostic Accuracy of Histopathologic and Cytopathologic Examination of Aspergillus Species
Akeesha A. Shah et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
Colonization With Small Conidia Aspergillus Species Is Associated With Bronchiolitis Obliterans Syndrome: A Two-Center Validation Study
S. S. Weigt et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Aspergillosis in Solid Organ Transplantation
N. M. Singh et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Association of bronchoalveolar lavage yield with chest computed tomography findings and symptoms in immunocompromised patients
Kyle R. Brownback et al.
ANNALS OF THORACIC MEDICINE (2013)
Population-Based Survey of Filamentous Fungi and Antifungal Resistance in Spain (FILPOP Study)
A. Alastruey-Izquierdo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Population Pharmacokinetics of Escalating Doses of Caspofungin in a Phase II Study of Patients with Invasive Aspergillosis
Gudrun Wuerthwein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Experimental Evidence That Granulocyte Transfusions Are Efficacious in Treatment of Neutropenic Hosts with Pulmonary Aspergillosis
Marife Martinez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
The water supply system as a potential source of fungal infection in paediatric haematopoietic stem cell units
Sabrina Mesquita-Rocha et al.
BMC INFECTIOUS DISEASES (2013)
Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes
John W. Baddley et al.
BMC INFECTIOUS DISEASES (2013)
Validity and Reliability of the St. George's Respiratory Questionnaire in Assessing Health Status in Patients With Chronic Pulmonary Aspergillosis
Khaled Al-shair et al.
CHEST (2013)
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria
R. Agarwal et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2013)
Neuro-ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature
Matthew J. Thurtell et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2013)
The Serum Galactomannan Index Predicts Mortality in Hematopoietic Stem Cell Transplant Recipients With Invasive Aspergillosis
Cynthia E. Fisher et al.
CLINICAL INFECTIOUS DISEASES (2013)
Aspergillosis due to Voriconazole Highly Resistant Aspergillus fumigatus and Recovery of Genetically Related Resistant Isolates From Domiciles
Jan W. M. van der Linden et al.
CLINICAL INFECTIOUS DISEASES (2013)
(1-3)-β-D-Glucan in Cerebrospinal Fluid Is Useful for the Diagnosis of Central Nervous System Fungal Infections
Malgorzata Mikulska et al.
CLINICAL INFECTIOUS DISEASES (2013)
Mycotic keratitis: epidemiology, diagnosis and management
P. A. Thomas et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Efficacy of DNA amplification in tissue biopsy samples to improve the detection of invasive fungal disease
M. J. Buitrago et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis
C. G. Baxter et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Fungal Disease of the Nose and Sinuses: An Updated Overview
Christopher Chang et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2013)
Oral Steroid Therapy in Chronic Rhinosinusitis with and without Nasal Polyposis
Brittany E. Howard et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2013)
Update on rifampin, rifabutin, and rifapentine drug interactions
Anne M. Baciewicz et al.
CURRENT MEDICAL RESEARCH AND OPINION (2013)
Is universal antifungal prophylaxis mandatory in lung transplant patients?
Joanna M. Schaenman
CURRENT OPINION IN INFECTIOUS DISEASES (2013)
Antifungal Therapy of Aspergillosis of the Central Nervous System and Aspergillus Endophthalmitis
Martin Hoenigl et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Differential expression of ATP-binding cassette and/or major facilitator superfamily class efflux pumps contributes to voriconazole resistance in Aspergillus flavus
S. Krishnan Natesan et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
Maiken C. Arendrup et al.
DRUG RESISTANCE UPDATES (2013)
Sphenoid sinus fungus ball
Alexandre Karkas et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2013)
Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study
G. Maschmeyer et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2013)
A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis
S. Kohno et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2013)
Novel immunologic classification of aspergillosis in adult cystic fibrosis
Caroline G. Baxter et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Steady-state pharmacokinetics and metabolism of voriconazole in patients
Marcus J. P. Geist et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Results of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence - a National Centre's experience
Shakil Farid et al.
JOURNAL OF CARDIOTHORACIC SURGERY (2013)
Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance
Michael A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Aspergillus PCR-Based Investigation of Fresh Tissue and Effusion Samples in Patients with Suspected Invasive Aspergillosis Enhances Diagnostic Capabilities
M. Reinwald et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant
Victor Monforte et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2013)
Aspergillus endocarditis in the era of new antifungals: Major role for antigen detection
Sebastien Riviere et al.
JOURNAL OF INFECTION (2013)
Aspergillus petrous apicitis associated with cerebral and peritubular abscesses in an immunocompetent man
Y. M. Bhatt et al.
JOURNAL OF LARYNGOLOGY AND OTOLOGY (2013)
Myeloid Growth Factors
Jeffrey Crawford et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2013)
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial
C. Orla Morrissey et al.
LANCET INFECTIOUS DISEASES (2013)
Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis
Werner J. Heinz et al.
MYCOSES (2013)
Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies
Ajaya K. Jha et al.
MYCOSES (2013)
Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature
Ritesh Agarwal et al.
MYCOSES (2013)
Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study)
I. Jarque et al.
MEDICAL MYCOLOGY (2013)
Aspergillus terreus Endogenous Endophthalmitis in a Nonimmunocompromised Patient with a History of Bronchiectasis
James Ng et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2013)
Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients
Soo-Han Choi et al.
PEDIATRIC BLOOD & CANCER (2013)
Diagnostic Performance of an Aspergillus-Specific Nested PCR Assay in Cerebrospinal Fluid Samples of Immunocompromised Patients for Detection of Central Nervous System Aspergillosis
Mark Reinwald et al.
PLOS ONE (2013)
Performance of Serum Biomarkers for the Early Detection of Invasive Aspergillosis in Febrile, Neutropenic Patients: A Multi-State Model
Michael Schwarzinger et al.
PLOS ONE (2013)
Diagnosis of Aspergillus niger Peritonitis in a Peritoneal Dialysis Patient by Peritoneal Galactomannan and β-D-Glucan Detection
O. Ates et al.
PERITONEAL DIALYSIS INTERNATIONAL (2013)
Culture-Negative Aspergillus Peritonitis Diagnosed by Peritoneal Biopsy
P. Indramohan et al.
PERITONEAL DIALYSIS INTERNATIONAL (2013)
Aerosolized Amphotericin B Lipid Complex as Adjunctive Treatment for Fungal Lung Infection in Patients with Cancer-Related Immunosuppression and Recipients of Hematopoietic Stem Cell Transplantation
Amar Safdar et al.
PHARMACOTHERAPY (2013)
The Evolving Role of Antifungal Susceptibility Testing
Gregory A. Eschenauer et al.
PHARMACOTHERAPY (2013)
Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum
Caroline G. Baxter et al.
THORAX (2013)
Preemptive treatment with voriconazole in lung transplant recipients
C. F. Neoh et al.
TRANSPLANT INFECTIOUS DISEASE (2013)
Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients
J. M. McLaughlin et al.
TRANSPLANT INFECTIOUS DISEASE (2013)
Micafungin Versus Amphotericin B Lipid Complex for the Prevention of Invasive Fungal Infections in High-Risk Liver Transplant Recipients
Hsin-Yun Sun et al.
TRANSPLANTATION (2013)
Does tranexamic acid stop haemoptysis?
Christian Arvei Moen et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2013)
The Mycotic Ulcer Treatment Trial A Randomized Trial Comparing Natamycin vs Voriconazole
N. Venkatesh Prajna et al.
JAMA OPHTHALMOLOGY (2013)
Anti-Aspergillus Prophylaxis in Lung Transplantation: A Systematic Review and Meta-analysis
Archana Bhaskaran et al.
CURRENT INFECTIOUS DISEASE REPORTS (2013)
Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections
Alessandro Pasqualotto et al.
Infection and Drug Resistance (2013)
Laboratory Diagnosis of Invasive Aspergillosis: From Diagnosis to Prediction of Outcome
Richard C. Barton
SCIENTIFICA (2013)
Clinical Impact of Cytochrome P450 2C19 Genotype on the Treatment of Invasive Aspergillosis under Routine Therapeutic Drug Monitoring of Voriconazole in a Korean Population
Si-Hyun Kim et al.
INFECTION AND CHEMOTHERAPY (2013)
A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients
Stijn I. Blot et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease
Keith C. Meyer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Risk Factors for Voriconazole Hepatotoxicity at 12 Weeks in Lung Transplant Recipients
M. -L. Luong et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Multifocal pulmonary aspergillomas: case series and review
Matthew Pendleton et al.
ADVANCES AGAINST ASPERGILLOSIS I (2012)
Aspergillus bronchitis without significant immunocompromise
Ales Chrdle et al.
ADVANCES AGAINST ASPERGILLOSIS I (2012)
The impact of azole resistance on aspergillosis guidelines
Sarah P. Georgiadou et al.
ADVANCES AGAINST ASPERGILLOSIS I (2012)
Fluoride Excess in Coccidioidomycosis Patients Receiving Long-Term Antifungal Therapy: an Assessment of Currently Available Triazoles
George R. Thompson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Effect of Posaconazole on Cyclosporine Blood Levels and Dose Adjustment in Allogeneic Blood and Marrow Transplant Recipients
Isabel Sanchez-Ortega et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Utilization of Omeprazole To Augment Subtherapeutic Voriconazole Concentrations for Treatment of Aspergillus Infections
Natalie K. Boyd et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting Concentration
Michael J. Dolton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity
Dimitra Mitsani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
Michael J. Dolton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Integrated Population Pharmacokinetic Analysis of Voriconazole in Children, Adolescents, and Adults
Lena E. Friberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug Monitoring
Michael J. Dolton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies
Anne Bergeron et al.
BLOOD (2012)
Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole
Bernhard Gerber et al.
BLOOD (2012)
Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics
H. R. Ashbee et al.
BONE MARROW TRANSPLANTATION (2012)
Voriconazole as primary antifungal prophylaxis in children undergoing allo-SCT
J. R. Molina et al.
BONE MARROW TRANSPLANTATION (2012)
Standardization of Aspergillus PCR diagnosis
J. Loeffler et al.
BONE MARROW TRANSPLANTATION (2012)
ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients
O. Marchetti et al.
BONE MARROW TRANSPLANTATION (2012)
A prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy-induced febrile neutropenia in children
Desiree Caselli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial
Venkatesh N. Prajna et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
β-Glucan Antigenemia Assay for the Diagnosis of Invasive Fungal Infections in Patients With Hematological Malignancies: A Systematic Review and Meta-Analysis of Cohort Studies From the Third European Conference on Infections in Leukemia (ECIL-3)
Frederic Lamoth et al.
CLINICAL INFECTIOUS DISEASES (2012)
The Safety of Amphotericin B Lipid Complex in Patients With Prior Severe Intolerance to Liposomal Amphotericin B
D. Farmakiotis et al.
CLINICAL INFECTIOUS DISEASES (2012)
Outbreak of Invasive Aspergillosis After Major Heart Surgery Caused by Spores in the Air of the Intensive Care Unit
T. Pelaez et al.
CLINICAL INFECTIOUS DISEASES (2012)
The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
Wan Beom Park et al.
CLINICAL INFECTIOUS DISEASES (2012)
Challenging Recommended Oral and Intravenous Voriconazole Doses for Improved Efficacy and Safety: Population Pharmacokinetics-Based Analysis of Adult Patients With Invasive Fungal Infections
Andres Pascual et al.
CLINICAL INFECTIOUS DISEASES (2012)
Post-diagnostic kinetics of the (1→3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia
S. Koo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Duration of Voriconazole Exposure: An Independent Risk Factor for Skin Cancer After Lung Transplantation
Fiona O. Zwald et al.
DERMATOLOGIC SURGERY (2012)
Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial
J. Cadranel et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infections
Joanne Livermore et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study
Joost Wauters et al.
INTENSIVE CARE MEDICINE (2012)
The role of combination antifungal therapy in the treatment of invasive aspergillosis: a systematic review
Musa A. Garbati et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2012)
Fungi and allergic lower respiratory tract diseases
Alan P. Knutsen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Fungal disease of the nose and paranasal sinuses
George R. Thompson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers
G. Krishna et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Cross-Reactivity of Fusarium spp. in the Aspergillus Galactomannan Enzyme-Linked Immunosorbent Assay
Anna Maria Tortorano et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Detection of Galactomannan in Bronchoalveolar Lavage Fluid Samples of Patients at Risk for Invasive Pulmonary Aspergillosis: Analytical and Clinical Validity
Jorien D'Haese et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis
Louis Y. A. Chai et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Diagnostic Accuracy of PCR Alone Compared to Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis: a Systematic Review
Tomer Avni et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
From the patient to the clinical mycology laboratory: how can we optimise microscopy and culture methods for mould identification?
Timoleon-Achilleas A. Vyzantiadis et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry
William J. Steinbach et al.
JOURNAL OF INFECTION (2012)
Concurrent lung infections in patients with hematological malignancies and invasive pulmonary aspergillosis: How firm is the Aspergillus diagnosis?
Sarah P. Georgiadou et al.
JOURNAL OF INFECTION (2012)
Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis
Yukihiro Hamada et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
The Performance of Real-Time PCR, Galactomannan, and Fungal Culture in the Diagnosis of Invasive Aspergillosis in Ventilated Patients with Chronic Obstructive Pulmonary Disease (COPD)
Valerio R. Aquino et al.
MYCOPATHOLOGIA (2012)
Serum galactomannan in cystic fibrosis patients colonized with Aspergillus species
Thomas A. Warren et al.
MEDICAL MYCOLOGY (2012)
Aspergillus Tracheobronchitis Report of 8 Cases and Review of the Literature
Mario Fernandez-Ruiz et al.
MEDICINE (2012)
Central Nervous System Aspergillosis A Series of 14 Cases From a General Hospital and Review of 123 Cases From the Literature
Themistoklis K. Kourkoumpetis et al.
MEDICINE (2012)
Voriconazole for Fungal Corneal Ulcers
Swapnil Parchand et al.
OPHTHALMOLOGY (2012)
Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis
I. Hadrich et al.
PATHOLOGIE BIOLOGIE (2012)
Discovery of a hapE Mutation That Causes Azole Resistance in Aspergillus fumigatus through Whole Genome Sequencing and Sexual Crossing
Simone M. T. Camps et al.
PLOS ONE (2012)
Diagnostic value of the serum galactomannan assay for invasive aspergillosis: It is less useful in non-haematological patients
Nam Su Ku et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2012)
Low incidence of invasive aspergillosis in allogeneic stem cell transplant recipients receiving amphotericin B inhalation prophylaxis
A. Nihtinen et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Diagnostic potential of nested PCR, galactomannan EIA, and Beta-D-glucan for invasive aspergillosis in pediatric patients
Parisa Badiee et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2012)
Surgical treatment for pulmonary aspergilloma: a 35-year experience in the Chinese population
Qian-Kun Chen et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2012)
Galactomannan Antigen Testing for Diagnosis of Invasive Aspergillosis in Pediatric Hematology Patients
Brian T. Fisher et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2012)
Complications of Allergic Fungal Sinusitis
Sarah Bozeman et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Antifungal Prophylaxis in Lung Transplantation-A World-wide Survey
C. F. Neoh et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Interrogation of Related Clinical Pan-Azole-Resistant Aspergillus fumigatus Strains: G138C, Y431C, and G434C Single Nucleotide Polymorphisms in cyp51A, Upregulation of cyp51A, and Integration and Activation of Transposon Atf1 in the cyp51A Promoter
Ahmed M. Albarrag et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Posaconazole in Human Serum: a Greater Pharmacodynamic Effect than Predicted by the Non-Protein-Bound Serum Concentration
Anders Lignell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Fractal Geometry and the Pharmacometrics of Micafungin in Overweight, Obese, and Extremely Obese People
Ronald G. Hall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Azole Resistance of Aspergillus fumigatus Biofilms Is Partly Associated with Efflux Pump Activity
Ranjith Rajendran et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis
O. A. Cornely et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan
Chien-Yuan Chen et al.
BMC INFECTIOUS DISEASES (2011)
Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study
E. Morello et al.
BONE MARROW TRANSPLANTATION (2011)
Performance of a Standardized Bronchoalveolar Lavage Protocol in a Comprehensive Cancer Center A Prospective 2-Year Study
Fotis Sampsonas et al.
CANCER (2011)
Voriconazole versus natamycin as primary treatment in fungal corneal ulcers
Ritu Arora et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2011)
Serum and Bronchoalveolar Lavage Fluid Galactomannan Assays in Patients with Pulmonary Aspergilloma
Seong Yeon Park et al.
CLINICAL INFECTIOUS DISEASES (2011)
Aspergillus Vertebral Osteomyelitis in Immunocompetent Hosts: Role of Triazole Antifungal Therapy
Alex Studemeister et al.
CLINICAL INFECTIOUS DISEASES (2011)
The Diagnostic Value of Halo and Reversed Halo Signs for Invasive Mold Infections in Compromised Hosts
Sarah P. Georgiadou et al.
CLINICAL INFECTIOUS DISEASES (2011)
Fluoride Excess and Periostitis in Transplant Patients Receiving Long-Term Voriconazole Therapy
Robert A. Wermers et al.
CLINICAL INFECTIOUS DISEASES (2011)
Earlier Response Assessment in Invasive Aspergillosis Based on the Kinetics of Serum Aspergillus Galactomannan: Proposal for a New Definition
Simone A. Nouer et al.
CLINICAL INFECTIOUS DISEASES (2011)
High-frequency Triazole Resistance Found In Nonculturable Aspergillus fumigatus from Lungs of Patients with Chronic Fungal Disease
David W. Denning et al.
CLINICAL INFECTIOUS DISEASES (2011)
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Alison G. Freifeld et al.
CLINICAL INFECTIOUS DISEASES (2011)
A retrospective series of gut aspergillosis in haematology patients
E. Kazan et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Histopathologic Diagnosis of Fungal Infections in the 21st Century
Jeannette Guarner et al.
CLINICAL MICROBIOLOGY REVIEWS (2011)
Voriconazole and itraconazole in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction
Mordechai R. Kramer et al.
CLINICAL TRANSPLANTATION (2011)
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility
K. L. Mortensen et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2011)
Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma
N. L. Smith et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450
Paul O. Gubbins
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Isolation of Aspergillus in three 2009 H1N1 influenza patients
Amesh A. Adalja et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2011)
A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis
Alexander M. Bryant et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study
Ban Hock Tan et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2011)
Peripheral neuropathy in patients on long-term triazole antifungal therapy
Caroline G. Baxter et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study)
Chiara Cattaneo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Aspergillus Species to the Triazoles
M. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Evaluation of Aspergillus PCR Protocols for Testing Serum Specimens
P. Lewis White et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Investigation of a cluster of cutaneous aspergillosis in a neonatal intensive care unit
K. A. Etienne et al.
JOURNAL OF HOSPITAL INFECTION (2011)
Homogenisation of cystic fibrosis sputum by sonication - An essential step for Aspergillus PCR
Caroline G. Baxter et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2011)
Skin cancer in solid organ transplant recipients: Advances in therapy and management Part I. Epidemiology of skin cancer in solid organ transplant recipients
Fiona O'Reilly Zwald et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Successful management of invasive aspergillosis presenting as pericarditis in an adult patient with chronic granulomatous disease
Klaus L. Mortensen et al.
MYCOSES (2011)
Inaugural bilateral aspergillus endophthalmitis in a seriously immunocompromised patient
A. Georgala et al.
MYCOSES (2011)
Serum galactomannan strongly correlates with outcome of invasive aspergillosis in acute leukaemia patients
Sun Hee Park et al.
MYCOSES (2011)
Value of consecutive galactomannan determinations for the diagnosis and prognosis of invasive pulmonary aspergillosis in critically ill chronic obstructive pulmonary disease
Hangyong He et al.
MEDICAL MYCOLOGY (2011)
Aspergillus endocarditis 2003-2009
Joe McCormack et al.
MEDICAL MYCOLOGY (2011)
Newer combination antifungal therapies for invasive aspergillosis
William J. Steinbach et al.
MEDICAL MYCOLOGY (2011)
Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection
Susan Julie Howard et al.
MEDICAL MYCOLOGY (2011)
Pharmacogenomics of the triazole antifungal agent voriconazole
Gerd Mikus et al.
PHARMACOGENOMICS (2011)
Tracheobronchial Manifestations of Aspergillus Infections
Rafal Krenke et al.
THESCIENTIFICWORLDJOURNAL (2011)
Spirometric findings as predictors of survival
Peter Lange
THORAX (2011)
Drug-drug interactions by azole antifungals: Beyond a dogma of CYP3A4 enzyme activity inhibition
Zdenek Dvorak
TOXICOLOGY LETTERS (2011)
Oral antifungal therapy for chronic rhinosinusitis and its subtypes: a systematic review
Thunchai Thanasumpun et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2011)
Surgery for aspergilloma: time trend towards improved results?
Anne Lejay et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2011)
Peritonitis Due to Aspergillus nidulans and Its Effective Treatment with Voriconazole: the First Case Report
S. Ulusoy et al.
PERITONEAL DIALYSIS INTERNATIONAL (2011)
Clinical Implications of Azole Resistance in Aspergillus fumigatus, the Netherlands, 2007-2009
Jan W. M. van der Linden et al.
EMERGING INFECTIOUS DISEASES (2011)
Intracameral Voriconazole Injection in the Treatment of Fungal Endophthalmitis Resulting From Keratitis
Ying-Cheng Shen et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Environmental Study of Azole-Resistant Aspergillus fumigatus and Other Aspergilli in Austria, Denmark, and Spain
Klaus Leth Mortensen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Pharmacokinetics, Safety, and Tolerability of Voriconazole in Immunocompromised Children
Thomas J. Walsh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Hepatic Safety of Voriconazole after Allogeneic Hematopoietic Stem Cell Transplantation
I. Amigues et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity
Cristina Cunha et al.
BLOOD (2010)
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation
John R. Wingard et al.
BLOOD (2010)
Caspofungin Use in Daily Clinical Practice for Treatment of Invasive Aspergillosis: Results of a Prospective Observational Registry
Johan Maertens et al.
BMC INFECTIOUS DISEASES (2010)
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD
U. Gergis et al.
BONE MARROW TRANSPLANTATION (2010)
Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT
O. Blennow et al.
BONE MARROW TRANSPLANTATION (2010)
Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study
R. Herbrecht et al.
BONE MARROW TRANSPLANTATION (2010)
Geoclimatic Influences on Invasive Aspergillosis after Hematopoietic Stem Cell Transplantation
Anil A. Panackal et al.
CLINICAL INFECTIOUS DISEASES (2010)
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database
Dimitrios P. Kontoyiannis et al.
CLINICAL INFECTIOUS DISEASES (2010)
Probable Invasive Aspergillosis without Prespecified Radiologic Findings: Proposal for Inclusion of a New Category of Aspergillosis and Implications for Studying Novel Therapies
Marcio Nucci et al.
CLINICAL INFECTIOUS DISEASES (2010)
Efficacy and Safety of Posaconazole for Chronic Pulmonary Aspergillosis
Timothy W. Felton et al.
CLINICAL INFECTIOUS DISEASES (2010)
Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET)
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2010)
Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation
E. Castagnola et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Voriconazole concentrations and outcome of invasive fungal infections
S. Miyakis et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Otomycosis: Diagnosis and treatment
Irina Vennewald et al.
CLINICS IN DERMATOLOGY (2010)
Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies
Me-Linh Luong et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
EUCAST BREAKPOINTS FOR ANTIFUNGALS
Juan L. Rodriguez-Tudela et al.
DRUG NEWS & PERSPECTIVES (2010)
Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort
J. W. Hiemenz et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2010)
Tacrolimus-Associated Posterior Reversible Encephalopathy Syndrome after Solid Organ Transplantation
Qisi Wu et al.
EUROPEAN NEUROLOGY (2010)
Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia
Amelie Chabrol et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study
Catherine Cordonnier et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases
Hae-Seong Nam et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes
S. Narreddy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
A. Espinel-Ingroff et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis
Sophia Koo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Acute Myeloid Leukemia or Myelodysplastic Syndrome in Randomized Controlled Clinical Trials of Cancer Chemotherapy With Granulocyte Colony-Stimulating Factor: A Systematic Review
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation
Victor Monforte et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)
Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: A multicenter trial in Japan
Shigeru Kohno et al.
JOURNAL OF INFECTION (2010)
Isolated fungus ball mimicking mucocele or frontal sinus tumour: a diagnostic pitfall
M. Popko et al.
JOURNAL OF LARYNGOLOGY AND OTOLOGY (2010)
Management of obstructive renal failure caused by bilateral renal aspergilloma in an immunocompetent newborn
J. D. Martinez-Pajares et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Review of the Basic and Clinical Pharmacology of Sulfobutylether-β-Cyclodextrin (SBECD)
David R. Luke et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplant
Jean El-Cheikh et al.
LEUKEMIA & LYMPHOMA (2010)
Amphotericin B refractory aspergillosis after itraconazole: evidence for significant antagonism
A. Schaffner et al.
MYCOSES (2010)
Evaluation of Calcofluor staining in the diagnosis of fungal corneal ulcer
J. Chander et al.
MYCOSES (2010)
Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India
Ritesh Agarwal et al.
MYCOSES (2010)
Risk Factors, Clinical Features, and Outcomes of Recurrent Fungal Keratitis after Corneal Transplantation
Weiyun Shi et al.
OPHTHALMOLOGY (2010)
PERITONEAL DIALYSIS-RELATED INFECTIONS RECOMMENDATIONS: 2010 UPDATE
Philip Kam-Tao Li et al.
PERITONEAL DIALYSIS INTERNATIONAL (2010)
Fungi and Molds following Lung Transplantation
S. M. Hosseini-Moghaddam et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients
D. Neofytos et al.
TRANSPLANT INFECTIOUS DISEASE (2010)
Impact of Mold Infections in Explanted Lungs on Outcomes of Lung Transplantation
Aniket Vadnerkar et al.
TRANSPLANTATION (2010)
Video-assisted thoracic surgery for pulmonary aspergilloma
Junji Ichinose et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2010)
Invasive Aspergillosis after Pandemic (H1N1) 2009
Asma Lat et al.
EMERGING INFECTIOUS DISEASES (2010)
Challenges and Pitfalls of Morphologic Identification of Fungal Infections in Histologic and Cytologic Specimens A Ten-Year Retrospective Review at a Single Institution
Ankur R. Sangoi et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
The role of itraconazole in recalcitrant fungal sinusitis
Kristin Seiberling et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2009)
Periostitis Secondary to Prolonged Voriconazole Therapy in Lung Transplant Recipients
T. F. Wang et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Antifungal Prophylaxis with Voriconazole or Itraconazole in Lung Transplant Recipients: Hepatotoxicity and Effectiveness
J. Cadena et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Antifungal Therapy of Aspergillus Invasive Otitis Externa: Efficacy of Voriconazole and Review
Perrine Parize et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
David Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric Studies
Mats O. Karlsson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: In Vitro and In Vivo Correlations of the Concentration- and Dose-Dependent Interactions between Anidulafungin and Voriconazole by Bliss Independence Drug Interaction Analysis
Vidmantas Petraitis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes
Eric Dannaoui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults
David Lebeaux et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
Marcie Tomblyn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin Bin patients after allo-SCT
H. Hebart et al.
BONE MARROW TRANSPLANTATION (2009)
Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated
D. Yokoe et al.
BONE MARROW TRANSPLANTATION (2009)
Galactomannan Serves as a Surrogate Endpoint for Outcome of Pulmonary Invasive Aspergillosis in Neutropenic Hematology Patients
Johan Maertens et al.
CANCER (2009)
Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
Roger J. M. Bruggemann et al.
CLINICAL INFECTIOUS DISEASES (2009)
Bronchoalveolar Lavage Fluid Galactomannan for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases
Johan Maertens et al.
CLINICAL INFECTIOUS DISEASES (2009)
Toxicodynamics of Itraconazole: Implications for Therapeutic Drug Monitoring
Jodi M. Lestner et al.
CLINICAL INFECTIOUS DISEASES (2009)
Empirical versus Preemptive Antifungal Therapy for High-Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial
Catherine Cordonnier et al.
CLINICAL INFECTIOUS DISEASES (2009)
Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis
C. Cordonnier et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Drug-Drug Interactions of Triazole Antifungal Agents in Multimorbid Patients and Implications for Patient Care
Yasmine Nivoix et al.
CURRENT DRUG METABOLISM (2009)
Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints
Paul E. Verweij et al.
DRUG RESISTANCE UPDATES (2009)
Immunotherapy in Elderly Transplant Recipients A Guide to Clinically Significant Drug Interactions
Dirk R. J. Kuypers
DRUGS & AGING (2009)
Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology
Georg Maschmeyer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis
A. Hidalgo et al.
EUROPEAN JOURNAL OF RADIOLOGY (2009)
Radiological findings of early invasive pulmonary aspergillosis in immune-compromised patients
O. R. Brook et al.
HEMATOLOGICAL ONCOLOGY (2009)
Invasive Pulmonary Aspergillosis in Patients With Antineutrophil Cytoplasmic Antibody Associated Vasculitis
Tao Su et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2009)
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients
C. Viscoli et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Utility of Galactomannan Enzyme Immunoassay and (1,3) beta-D-Glucan in Diagnosis of Invasive Fungal Infections: Low Sensitivity for Aspergillus fumigatus Infection in Hematologic Malignancy Patients
R. Y. Hachem et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network
John W. Baddley et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and Safety
Victor Monforte et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2009)
Pulmonary aspergilloma: Analysis of prognosis in relation to symptoms and treatment
Jin Gu Lee et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2009)
Infection Control Measures to Prevent Invasive Mould Diseases in Hematopoietic Stem Cell Transplant Recipients
Kimberly Partridge-Hinckley et al.
MYCOPATHOLOGIA (2009)
Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery
Caspar J. Hodiamont et al.
MEDICAL MYCOLOGY (2009)
Paradoxical echinocandin activity: a limited in vitro phenomenon?
Nathan P. Wiederhold
MEDICAL MYCOLOGY (2009)
Chronic Granulomatous Disease: The European Experience
J. Merlijn van den Berg et al.
PLOS ONE (2009)
Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis
D. P. Kontoyiannis et al.
TRANSPLANT INFECTIOUS DISEASE (2009)
False-Positive Results of Aspergillus Galactomannan Antigenemia in Liver Transplant Recipients
Jesus Fortun et al.
TRANSPLANTATION (2009)
Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure
Susan J. Howard et al.
EMERGING INFECTIOUS DISEASES (2009)
Galactomannan in bronchoalveolar lavage fluid - A tool for diagnosing aspergillosis in intensive care unit patients
Wouter Meersseman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus
Juan Luis Rodriguez-Tudela et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy
Ray Y. Hachem et al.
CANCER (2008)
Performance Characteristics of the Platelia Aspergillus Enzyme Immunoassay for Detection of Aspergillus Galactomannan Antigen in Bronchoalveolar Lavage Fluid
S. Husain et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes
Andres Pascual et al.
CLINICAL INFECTIOUS DISEASES (2008)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: Clinical and research implications
Marisa H. Miceli et al.
CLINICAL INFECTIOUS DISEASES (2008)
Reversed halo sign in invasive pulmonary fungal infections
Hisham Wahba et al.
CLINICAL INFECTIOUS DISEASES (2008)
Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia:: A randomized, placebo-controlled trial
Bart J. Rijnders et al.
CLINICAL INFECTIOUS DISEASES (2008)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw et al.
CLINICAL INFECTIOUS DISEASES (2008)
EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds - Subcommittee on antifungal susceptibility testing (AFST) of the ESCMID European committee for antimicrobial susceptibility testing (EUCAST)
J. -L. Rodriquez Tudela et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B
Amparo Sole
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Ototopical antifungals and otomycosis: A review
Raymundo Munguia et al.
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY (2008)
Levels of amphotericin B lipid formulations in ascites
Stefan Weiler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
A man with changes in mental status after liver transplantation - Disseminated cryptococcosis with cryptococcal meningitis in a liver-allograft recipient
Jay A. Fishman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation
Pierre-Yves Bochud et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis
Randall Hayden et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Efficiency and Safety of Inhaled Amphotericin B Lipid Complex (Abelcet) in the Prophylaxis of Invasive Fungal Infections Following Lung Transplantation
J. M. Borro et al.
TRANSPLANTATION PROCEEDINGS (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Plasminogen Alleles Influence Susceptibility to Invasive Aspergillosis
Aimee K. Zaas et al.
PLOS GENETICS (2008)
Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism
Eveline Snelders et al.
PLOS MEDICINE (2008)
Combination antifungal therapy: From bench to bedside
Baldeep Wirk et al.
Current Infectious Disease Reports (2008)
Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis
Gerardo Quezada et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies -: A randomized pilot study (Combistrat trial)
Denis Caillot et al.
CANCER (2007)
Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: Analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease
Jo-Anne H. van Burik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Aspergillus infection in lung transplant patients:: incidence and prognosis
M. Iversen et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2007)
Mould-active azoles: pharmacokinetics, drug interactions in neutropenic patients
Paul O. Gubbins
CURRENT OPINION IN INFECTIOUS DISEASES (2007)
Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients
Lillian S. Chou et al.
PHARMACOTHERAPY (2007)
Drug-drug interactions in clinical practice
Fanny Depont et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Diagnostic accuracy of bronchoalveolar ravage samples in Immunosuppressed patients with suspected pneumonia:: Analysis of a protocol
Lazaro Velez et al.
RESPIRATORY MEDICINE (2007)
Technical aspects of bronchoalveolar lavage: Recommendations for a standard procedure
Robert P. Baughman
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Grappo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial
Andrea Gallamini et al.
BLOOD (2007)
Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole
S. Trifilio et al.
BONE MARROW TRANSPLANTATION (2007)
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection
P. de Fabritiis et al.
BONE MARROW TRANSPLANTATION (2007)
Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: A systematic review
Nicole M. Kuderer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients
William J. Steinbach et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations
E. Mellado et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study
C. M. Lowry et al.
TRANSPLANT INFECTIOUS DISEASE (2007)
Inherited long QT syndrome revealed by antifungals drug-drug interaction
C. Eiden et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2007)
Surgical treatment of Aspergillus mycetomas of the maxillary sinus:: Review of the literature
Fabio Costa et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2007)
Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay
Johan A. Maertens et al.
CLINICAL INFECTIOUS DISEASES (2007)
Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)
Oliver A. Cornely et al.
CLINICAL INFECTIOUS DISEASES (2007)
Serum and intraperitoneal levels of amphotericin B and flucytosine during intravenous treatment of critically ill patients with Candida peritonitis
Peter H. J. van der Voort et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Fungus balls of the paranasal sinuses: a review
Pierre Grosjean et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2007)
Relevant imaging findings of cerebral aspergillosis on MRI:: a retrospective case-based study in immunocompromised patients
A. Gabelmann et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Adverse effects of voriconazole:: Analysis of the French pharmacovigilance database
Celine Eiden et al.
ANNALS OF PHARMACOTHERAPY (2007)
Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients
Juliette Camuset et al.
CHEST (2007)
Comparison of CT features of Aspergillus and bacterial pneumonia in severely neutropenic patients
Costanza Bruno et al.
JOURNAL OF THORACIC IMAGING (2007)
Hussain HM, Hotopf M, Oyebode F. Atypical antipsychotic drugs and Alzheimer's disease - (Retraction of vol 356, pg 416, 2007)
Hadi Meeran Hussain
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Outbreak of aspergillosis infections among lung transplant recipients
Yael Raviv et al.
TRANSPLANT INTERNATIONAL (2007)
Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid
Chadi A. Hage et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign
Reginald E. Greene et al.
CLINICAL INFECTIOUS DISEASES (2007)
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
Oliver A. Cornely et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
Andrew J. Ullmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2007)
Endobronchial fungal disease: An under-recognized entity
Demet Karnak et al.
RESPIRATION (2007)
Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis
Johan Maertens et al.
CANCER (2006)
Voriconazole prophylaxis in lung transplant recipients
S. Husain et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Primary invasive aspergillosis of the digestive tract: Report of two cases and review of the literature
P. Eggimann et al.
INFECTION (2006)
The concentration-dependent nature of in vitro amphotericin B-itraconazole interaction against Aspergillus fumigates:: isobolographic and response surface analysis of complex pharmacodynamic interactions
Joseph Meletiadis et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation:: a retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Rodrigo Martino et al.
BLOOD (2006)
Multi-azole resistance in Aspergillus fumigatus
Susan J. Howard et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Otomycosis: Clinical features and treatment implications
Tang Ho et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2006)
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis
David W. Denning et al.
JOURNAL OF INFECTION (2006)
Human pharmacogenomic variations and their implications for antifungal efficacy
Joseph Meletiadis et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
Triazole-polyene antagonism in experimental invasive pulmonary aspergillosis: In vitro and in vivo correlation
Joseph Meletiadis et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Reactivity of (1→3)-β-D-glucan assay with commonly used intravenous antimicrobials
Francisco M. Marty et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients
E. G. Playford et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2006)
Management of severe hemoptysis from pulmonary aspergilloma using endovascular embolization
Peter Corr
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2006)
2006 update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline
Thomas J. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Aspergillus bronchitis in cystic fibrosis
David Shoseyov et al.
CHEST (2006)
Fungal osteoarticular infections in patients treated at a comprehensive cancer centre: a 10-year retrospective review
P. R. Kumashi et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients
Paul O. Gubbins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections
Jan G. den Hollander et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Usefulness of sequential Aspergillus galactomannan antigen detection combined with early radiologic evaluation for diagnosis of invasive pulmonary aspergillosis in patients undergoing allogeneic stem cell transplantation
A. Busca et al.
TRANSPLANTATION PROCEEDINGS (2006)
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
T Bongartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Diagnosis of invasive aspergillosis using a galactomannan assay: A meta-analysis
CD Pfeiffer et al.
CLINICAL INFECTIOUS DISEASES (2006)
Reducing warfarin medication interactions - An interrupted time series evaluation
AC Feldstein et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Voriconazole therapeutic drug monitoring
J Smith et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a guinea pig model of invasive aspergillosis
WR Kirkpatrick et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients:: A prospective, multicenter, observational study
N Singh et al.
TRANSPLANTATION (2006)
Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection
AJ Ullmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities
K Tan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Diagnostic MR imaging features of craniocerebral Aspergillosis of sino-nasal origin in immunocompetent patients
AA Siddiqui et al.
ACTA NEUROCHIRURGICA (2006)
Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections
DK Benjamin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosis
KV Clemons et al.
MEDICAL MYCOLOGY (2006)
Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies
GN Mattiuzzi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies
NV Sipsas et al.
CLINICAL INFECTIOUS DISEASES (2006)
Pharmacokinetic/pharmacodynamic profile of voriconazole
Ursula Theuretzbacher et al.
CLINICAL PHARMACOKINETICS (2006)
Recommendations for managing Aspergillus osteomyelitis and joint infections based on a review of the literature
Andrew Kirby et al.
JOURNAL OF INFECTION (2006)
Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder
W. J. F. M. van der Velden et al.
ANNALS OF HEMATOLOGY (2006)
Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): Efficacy and drug interaction
D Shitrit et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Safety and pharmacokinetics of coadministered voriconazole and anidulafungin
JA Dowell et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents
TJ Walsh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Galactomannan and computed tomography - Based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: A prospective feasibility study
J Maertens et al.
CLINICAL INFECTIOUS DISEASES (2005)
Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA)
JI Ito et al.
BONE MARROW TRANSPLANTATION (2005)
Improved outcome in central nervous system aspergillosis, using voriconazole treatment
S Schwartz et al.
BLOOD (2005)
Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies
M Weisser et al.
CLINICAL INFECTIOUS DISEASES (2005)
Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies:: a meta-analysis of randomised-controlled trials
KZ Vardakas et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Activity of posaconazole in the treatment of central nervous system fungal infections
P Pitisuttithum et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Laboratory diagnosis of invasive aspergillosis
WW Hope et al.
LANCET INFECTIOUS DISEASES (2005)
Multicenter clinical evaluation of the (1→3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans
L Ostrosky-Zeichner et al.
CLINICAL INFECTIOUS DISEASES (2005)
Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF
E Sionov et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Safety, tolerability, and pharmacokinetics of micafungin (FK463) in febrile neutropenic pediatric patients
NL Seibel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Bifidobacterial lipoglycan as a new cause for false-positive Platelia Aspergillus enzyme-linked immunosorbent assay reactivity
MAS Mennink-Kersten et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: Results from the caspofungin invasive aspergillosis study
J Maertens et al.
CLINICAL INFECTIOUS DISEASES (2005)
Risk factors for invasive aspergillosis in solid-organ transplant recipients: A case-control study
J Gavalda et al.
CLINICAL INFECTIOUS DISEASES (2005)
Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer
G Chamilos et al.
CLINICAL INFECTIOUS DISEASES (2005)
The invasive and saprophytic syndromes due to Aspergillus spp.
WW Hope et al.
MEDICAL MYCOLOGY (2005)
Voriconazole for invasive bone aspergillosis: A worldwide experience of 20 cases
H Mouas et al.
CLINICAL INFECTIOUS DISEASES (2005)
The safety of interferon-γ-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation
A Safdar et al.
CANCER (2005)
Aspergillus infections in transplant recipients
N Singh et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Combination treatment of invasive fungal infections
PK Mukherjee et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis
F Kellett et al.
RESPIRATORY MEDICINE (2005)
Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma
J Chen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Pharmacokinetics of single, oral-dose voriconazole in peritoneal dialysis patients
LW Peng et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Contribution of (1 -> 3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan
C Pazos et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Prospective assessment of Platelia™ Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients
S Husain et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients
C Cordonnier et al.
BONE MARROW TRANSPLANTATION (2004)
Risk factors of invasive aspergillosis after heart transplantation:: Protective role of oral itraconazole prophylaxis
P Muñoz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Combination antifungal therapy
MD Johnson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Ltraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants
KA Marr et al.
BLOOD (2004)
Cyclophosphamide metabolism is affected by azole antifungals
KA Marr et al.
BLOOD (2004)
Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients
RH Drew et al.
TRANSPLANTATION (2004)
Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detection
MASH Mennink-Kersten et al.
LANCET (2004)
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
TJ Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Combination antifungal therapy for invasive aspergillosis
KA Marr et al.
CLINICAL INFECTIOUS DISEASES (2004)
Invasive aspergillosis in critically ill patients without malignancy
W Meersseman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation
AP Grigg et al.
BONE MARROW TRANSPLANTATION (2004)
Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: Variables that affect performance
KA Marr et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
β-D-glucan as a diagnostic adjunct for invasive fungal infections:: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome
Z Odabasi et al.
CLINICAL INFECTIOUS DISEASES (2004)
Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid
B Musher et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy
J Maertens et al.
CLINICAL INFECTIOUS DISEASES (2004)
Substitutions at methionine 220 in the 14α-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs
E Mellado et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Toward more effective antifungal therapy: the prospects of combination therapy
DP Kontoyiannis et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Newer systemic antifungal agents - Pharmacokinetics, safety and efficacy
HW Boucher et al.
DRUGS (2004)
Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center
T Fukuda et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation
JAH van Burik et al.
CLINICAL INFECTIOUS DISEASES (2004)
Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration
TJ Walsh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Efficacy of galactomannan antigen in the platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients
EJ Kwak et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis
MASH Mennink-Kersten et al.
LANCET INFECTIOUS DISEASES (2004)
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus
WJ Steinbach et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies:: Evidence from a meta-analysis of 3,597 patients
A Glasmacher et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam
A Sulahian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Polyene and cytokine treatment of experimental aspergillosis
E Sionov et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2003)
Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients:: a cohort study
FM Marty et al.
BLOOD (2003)
Combination and sequential antifungal therapy for invasive aspergillosis: Review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001
WJ Steinbach et al.
CLINICAL INFECTIOUS DISEASES (2003)
Clinical impact of drug-drug interactions with systemic azole antifungals
DW Bates et al.
DRUGS OF TODAY (2003)
Fungal peritonitis in 15 patients on continuous ambulatory peritoneal dialysis (CAPD)
P Manzano-Gayosso et al.
MYCOSES (2003)
Chronic cavitary and Fibrosing pulmonary and pleural aspergillosis: Case series, proposed nomenclature change, and review
DW Denning et al.
CLINICAL INFECTIOUS DISEASES (2003)
Molecular epidemiology of Aspergillus fumigatus isolates recovered from water, air, and patients shows two clusters of genetically distinct strains
A Warris et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies
DP Kontoyiannis et al.
CANCER (2003)
Combination therapy in treatment of experimental pulmonary aspergillosis: Synergistic interaction between an antifungal triazole and an echinocandin
V Petraitis et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Diagnosis of invasive septate mold infections - A correlation of microbiological culture and histologic or cytologic examination
JJ Tarrand et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome
J Lundin et al.
BLOOD (2003)
Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST)
M Cuenca-Estrella et al.
CLINICAL MICROBIOLOGY AND INFECTION (2003)
Triad of acute infusion-related reactions associated with liposomal amphotericin B: Analysis of clinical and epidemiological characteristics
MM Roden et al.
CLINICAL INFECTIOUS DISEASES (2003)
Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients - A multicenter, randomized trial
DJ Winston et al.
ANNALS OF INTERNAL MEDICINE (2003)
Voriconazole treatment for less-common, emerging, or refractory fungal infections
JR Perfect et al.
CLINICAL INFECTIOUS DISEASES (2003)
Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis
MJ Becker et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Peritonitis due to Aspergillus and zygomycetes in patients undergoing peritoneal dialysis:: report of 2 cases and review of the literature
EC Nannini et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2003)
Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole
AM Nascimento et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole
R Hyland et al.
DRUG METABOLISM AND DISPOSITION (2003)
Pathogenic molds (including Aspergillus species) in hospital water distribution systems:: a 3-year prospective study and clinical implications for patients with hematologic malignancies
EJ Anaissie et al.
BLOOD (2003)
British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections
DW Denning et al.
LANCET INFECTIOUS DISEASES (2003)
Aspergillus infections after lung transplantation:: Clinical differences in type of transplant and implications for management
N Singh et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2003)
Aspergillus infection in lung transplant recipients with cystic fibrosis - Risk factors and outcomes comparison to other types of transplant recipients
M Helmi et al.
CHEST (2003)
A point mutation in the 14α-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus
TM Diaz-Guerra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Refractory aspergillus pneumonia in patients with acute leukemia - Successful therapy with combination caspofungin and liposomal amphotericin
TB Aliff et al.
CANCER (2003)
Voriconazole potentiates warfarin-induced prothrombin time prolongation
L Purkins et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Multidrug resistance in Aspergillus fumigatus.
A Warris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
KA Marr et al.
BLOOD (2002)
Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies
H Hebart et al.
BLOOD (2002)
Late Aspergillus fumigatus endomyocarditis with brain abscess as a lethal complication after heart transplantation
F Rueter et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2002)
Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients
J Maertens et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation:: a comparative analysis of feasibility and outcome for community donors versus related donors
K Hübel et al.
TRANSFUSION (2002)
Cleaning patient shower facilities:: A novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds
EJ Anaissie et al.
CLINICAL INFECTIOUS DISEASES (2002)
Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis
RE Lewis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Efficacy of high-efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies
T Hahn et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2002)
A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients
R Bowden et al.
CLINICAL INFECTIOUS DISEASES (2002)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate
JW Slaven et al.
FUNGAL GENETICS AND BIOLOGY (2002)
Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis
WR Kirkpatrick et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Antifungal prophylaxis for severely neutropenic chemotherapy recipients -: A meta-analysis of randomized-controlled clinical trials
EJ Bow et al.
CANCER (2002)
The clinical spectrum of pulmonary aspergillosis
AO Soubani et al.
CHEST (2002)
Aspergillus cholangitis:: A late complication after kasai portoenterostomy
SH Erdman et al.
JOURNAL OF PEDIATRIC SURGERY (2002)
Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis
C Viscoli et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: A dose escalation study
HM Lazarus et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients
R Herbrecht et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Pathogenic Aspergillus species recovered from a hospital water system:: A 3-year prospective study
EJ Anaissie et al.
CLINICAL INFECTIOUS DISEASES (2002)
Imaging findings in intracranial aspergillosis
K Yamada et al.
ACADEMIC RADIOLOGY (2002)
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
TJ Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Interaction of common azole antifungals with P glycoprotein
EJ Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Bronchial artery embolization - Experience with 54 patients
KL Swanson et al.
CHEST (2002)
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
DW Denning et al.
CLINICAL INFECTIOUS DISEASES (2002)
Enhanced vincristine neurotoxicity from drug interactions: Case report and review of literature
RK Sathiapalan et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2001)
Fusariosis associated with pathogenic Fusarium species colonization of a hospital water system:: A new paradigm for the epidemiology of opportunistic mold infections
EJ Anaissie et al.
CLINICAL INFECTIOUS DISEASES (2001)
Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy - A randomized, controlled trial
M Boogaerts et al.
ANNALS OF INTERNAL MEDICINE (2001)
Safety of aerosolized amphotericin B lipid complex in lung transplant recipients
SM Palmer et al.
TRANSPLANTATION (2001)
Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics
L Willems et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2001)
Aspergillosis case - Fatality rate: Systematic review of the literature
SJ Lin et al.
CLINICAL INFECTIOUS DISEASES (2001)
Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients
R Herbrecht et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2001)
Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia
D Caillot et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Fungal endocarditis: Evidence in the world literature, 1965-1995
ME Ellis et al.
CLINICAL INFECTIOUS DISEASES (2001)
Impact of BAL in the management of pneumonia with treatment failure -: Positivity of BAL culture under antibiotic therapy
JCP Gomes et al.
CHEST (2000)
Phylogenetic species recognition and species concepts in fungi
JW Taylor et al.
FUNGAL GENETICS AND BIOLOGY (2000)
Efficacy and safety of Amphotericin B Lipid Complex Injection (ABLC) in solid-organ transplant recipients with invasive fungal infections
P Linden et al.
CLINICAL TRANSPLANTATION (2000)
Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B
JL Harousseau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Aspergillus valve endocarditis in patients without prior cardiac surgery
T Gumbo et al.
MEDICINE (2000)
Chronic granulomatous disease - Report on a national registry of 368 patients
JA Winkelstein et al.
MEDICINE (2000)
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.
DA Stevens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Effects of the antifungal agents on oxidative drug metabolism - Clinical relevance
K Venkatakrishnan et al.
CLINICAL PHARMACOKINETICS (2000)
A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients
M Nucci et al.
CLINICAL INFECTIOUS DISEASES (2000)
Diagnosis of pulmonary aspergillosis using optical brighteners
S Andreas et al.
EUROPEAN RESPIRATORY JOURNAL (2000)
Refinements of environmental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit
CL Thio et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2000)
Successful treatment of aspergillus brain abscess in a child with acute lymphoblastic leukemia
A Ng et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2000)
Share Paper
